Company
Ark Biotech
Faster development. More robust manufacturing.
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Customers
- Top biopharma companies and CDMOs
- Legal name
- Ark Biotech
Claim, correct or request removal
Record updated 28 September 2026
About
At Ark, we are transforming bioprocessing by championing a model-first approach that combines biology, chemistry, and physics with the predictive power of machine learning and AI.
Funding snapshot
- Total raised
- $21.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $8.2M2024-05-10
Funding rounds
- Round, 2024
- $8.2M2024-05-10, SEC form D sold, 8 investors
- Round, 2022
- $5M2022-10-07, SEC form D sold, 5 investors
- Round, 2022
- $6M2022-04-21, SEC form D sold, 12 investors
- Round, 2021
- $2.5M2021-12-10, SEC form D sold, 10 investors
Products
- Web
- Ark
Loading relationship preview